Hefner Jochen, Berberich Sara, Lanvers Elena, Sanning Maria, Steimer Ann-Kathrin, Kunzmann Volker
Section of Psychosomatic Medicine, Department of Internal Medicine II, University of Wuerzburg, Bavaria, Germany,
Medical Student, Faculty of Medicine, University of Wuerzburg, Bavaria, Germany.
Patient Prefer Adherence. 2018 Sep 21;12:1875-1887. doi: 10.2147/PPA.S169354. eCollection 2018.
The prescribing of oral chemotherapy agents has introduced the new challenge of ensuring patients' adherence to therapy. Aspects of a close patient-doctor relationship are reported to be correlated with adherence to oral anticancer drugs, but data on capecitabine are scarce.
Sixty-four outpatients with a diagnosis of cancer and prescribed capecitabine were recruited from a German Comprehensive Cancer Center. We used the Patient-Doctor Relationship Questionnaire (PDRQ-9), the Medical Adherence Rating Scale (MARS), the Beliefs about Medicines Questionnaire (BMQ), and the Satisfaction with Information about Medicines Scale (SIMS) to assess patients' perceptions and behavior. Medical data were extracted from the charts.
Non-adherence was reported by 20% of the 64 participants. The perceived quality of the patient-doctor relationship was high in general, but it did not emerge as a predictor of adherence in our survey (odds ratio [OR]=0.915, =0.162, 95% CI=0.808-1.036). However, beliefs about medicine (OR=1.268, <0.002; 95% CI=1.090-1.475) as well as satisfaction with information about medicine (OR=1.252, <0.040, 95% CI=1.010-1.551) were predictors of adherence and the quality of the patient-doctor relationship was correlated with both variables (=0.373, =0.002 for SIMS sum score; =0.263, =0.036 for BMQ necessity/concern difference). Overall, adherence to capecitabine was high with a conviction that the therapy is necessary. However, concerns were expressed regarding the long-term effect of capecitabine use. Patients have unmet information needs regarding interactions of capecitabine with other medicines and the impairment of their intimate life.
In order to ensure adherence to capecitabine, our results seem to encourage the default use of modern and perhaps more impersonal means of information brokerage (eg, email, internet). However, the contents of some of patients' informational needs as well as the associations of patients' beliefs and satisfaction about the information received suggest a benefit from a trustful patient-doctor relationship.
口服化疗药物的处方带来了确保患者坚持治疗这一新挑战。据报道,密切的医患关系的某些方面与口服抗癌药物的依从性相关,但关于卡培他滨的数据却很稀少。
从德国一家综合癌症中心招募了64名诊断为癌症并开具卡培他滨处方的门诊患者。我们使用医患关系问卷(PDRQ - 9)、药物治疗依从性评定量表(MARS)、药物信念问卷(BMQ)和药物信息满意度量表(SIMS)来评估患者的认知和行为。从病历中提取医疗数据。
64名参与者中有20%报告存在不依从情况。总体而言,医患关系的感知质量较高,但在我们的调查中它并未成为依从性的预测因素(优势比[OR]=0.915,P = 0.162,95%置信区间=0.808 - 1.036)。然而,药物信念(OR = 1.268,P < 0.002;95%置信区间=1.090 - 1.475)以及对药物信息的满意度(OR = 1.252,P < 0.040,95%置信区间=1.010 - 1.551)是依从性的预测因素,并且医患关系的质量与这两个变量相关(对于SIMS总分,r = 0.373,P = 0.002;对于BMQ必要性/关注差异,r = 0.263,P = 0.036)。总体而言,对卡培他滨的依从性较高,患者坚信该治疗是必要的。然而,患者对卡培他滨长期使用的影响表示担忧。患者在卡培他滨与其他药物相互作用以及对其亲密生活的影响方面存在未满足的信息需求。
为确保对卡培他滨的依从性,我们的结果似乎鼓励默认使用现代且可能更客观的信息传播方式(如电子邮件、互联网)。然而,患者部分信息需求的内容以及患者对所获信息的信念和满意度之间的关联表明,信任的医患关系是有益的。